🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cardiotoxicity

Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) NCT07761910Phase 21 site📍 Indianapolis Indiana University · Tests: PET/CT 18F-Flurpiridaz Rest/Stress Test, Coronary CT Angiography (CCTA), 18F-Flurpiridaz PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study NCT07874828Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Tirzepatide Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care NCT03882580n/a3 sites📍 Paris📍 Paris📍 Paris Groupe Hospitalier Pitie-Salpetriere · Tests: Anti-Cancer Agents Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. NCT07157670n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity NCT06214195Phase 31 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: Shengmai San (ingredients include ginseng, Ophiopogon japonicus, and Schisandra chinensis) Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer NCT06781762n/a1 site📍 Toronto University of Toronto · Tests: N/A (Usual Care) The STOP-MED CTRCD Trial NCT06183437Phase 414 sites📍 Los Angeles📍 Boston📍 Melbourne Dinesh Thavendiranathan · Tests: Stopping Heart Failure Medication(s) ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies NCT07191730n/a1 site📍 Caen University Hospital, Caen Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients NCT07233499Phase 21 site📍 Cairo Ain Shams University · Tests: Nebivolol 5 mg Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study NCT05851053n/a1 site📍 Groningen University Medical Center Groningen · Tests: Echocardiography Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer NCT05787834NA1 site📍 Buffalo Roswell Park Cancer Institute · Tests: Best Practice, Medical Device Usage and Evaluation, Respiratory Muscle Training, Survey Administration Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies NCT06664528n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: ECHOCARDIOGRAPHY, ELECTROCARDIOGRAPHY (ECG), LABORATORY TESTS NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity NCT06340516NA1 site📍 Gothenburg Vastra Gotaland Region · Tests: Plasma NT-proBNP Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity NCT07070765NA2 sites📍 Aberdeen📍 Aberdeen University of Aberdeen · Tests: Sodium-glucose transport-2 (SGLT-2) inhibitors, Standard medical treatment Chronic Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer NCT06776458n/a1 site📍 Toronto University of Toronto · Tests: N/A - Usual Care The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial NCT05023785NA1 site📍 Toronto University Health Network, Toronto · Tests: Cardio-oncology Rehabilitation (CORE) Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted NCT05559164Phase 210 sites📍 Elizabeth📍 Hamilton📍 Jersey City Rutgers, The State University of New Jersey · Tests: Lipitor 40mg Tablet Cardiotoxicity in Breast Cancer Patients NCT06491680Phase 41 site📍 Cairo Helwan University · Tests: Dapagliflozin 10mg Tab Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity. NCT07663357n/a6 sites📍 Fortaleza📍 Recife📍 Florianópolis Beneficência Portuguesa de São Paulo Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters. (LOCATION MATTERS) NCT06361784n/a1 site📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-B NCT06443645n/a1 site📍 Strasbourg Centre Paul Strauss · Tests: Anthracycline COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA) NCT05258448n/a1 site📍 Odense C Odense University Hospital · Tests: Chemoradiotherapy Cardiac Side Effects of Systemic Therapy in Early-Stage Breast Cancer NCT07588425n/a1 site📍 Ankara Fatih GURLER Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial) NCT03711110NA14 sites📍 Santiago de Compostela📍 Galdakao📍 Barcelona Fundación Instituto de Estudios de Ciencias de la Salud de … · Tests: Intensive cardiovascular monitoring, No intervention Biomarkers to Predict Cancer Therapy-related Cardiotoxicity NCT06353191n/a4 sites📍 Scottsdale📍 Jacksonville📍 Tampa Mayo Clinic · Tests: Non-Interventional Study Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer Therapy NCT07528586NA1 site📍 Stuttgart Robert Bosch Gesellschaft für Medizinische Forschung mbH (R… · Tests: CMR based measurement of cardiotoxicity, biosampling for scientific research in study-specific biobank Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients NCT02772367n/a1 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: skin punch biopsy Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma NCT06220032Phase 325 sites📍 's-Hertogenbosch📍 Almelo📍 Amstelveen Stichting Hemato-Oncologie voor Volwassenen Nederland · Tests: Dexrazoxane, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year NCT06930521NA1 site📍 Toronto Women's College Hospital · Tests: Intervention - Low Risk Group OR Intermediate Risk Group RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer NCT05256745Phase 1, Phase 23 sites📍 Washington D.C.📍 Washington D.C.📍 Hackensack Georgetown University · Tests: TTP488, ddAC/ddT, TC, TCHP, Chemotherapy regimen that includes ddAC
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy